
Amid Gambia row, Maiden Pharma’s HP plant cough syrups flagged ‘spurious’
CDSCO in its December 2022 alert says five cough syrup samples produced by Maiden at its Baddi plant are "not of standard quality".
CDSCO in its December 2022 alert says five cough syrup samples produced by Maiden at its Baddi plant are "not of standard quality".
The Central Drugs Standard Control Organisation (CDSCO) has stopped all manufacturing activities at Noida-based Marion Biotech.
CDSCO along with UP Drug Control Administration had carried out a joint inspection of Marion's Noida facility, says health minister Mansukh Mandaviya.
Maiden Pharmaceutical holds manufacturing permission for these products for export only, the government says.
CBI says the accused was trying to exert undue influence on officers of CDSCO to waive the Phase III trial of "Insulin Aspart Injection".
Government sets up experts’ panel to determine compensation amount.